Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1669-1673

  Martínez Martínez, Luis ^a,b   Pascual, Alvaro ^a,b   Hernández Allés, Santiago ^c   Alvarez Díaz, Dolores ^c   Suárez, Ana Isabel ^b   Tran, John ^d   Benedí, Vicente Javier ^c   Jacoby, George A ^d  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c INSTITUTO MEDITERRÁNEO DE ESTUDIOS AVANZADOS   (Spain)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 METHYL 1,2,3 TRIAZOL 4 YLMETHYLENE)PENEM 3 CARBOXYLIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL;

EID: 0345379318     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1669     Document Type: Article

References (38)

1. Albertí, S., F. Rodríguez-Quiñones, T. Schirmer, G. Rummel, J. M. Tomás, J. P. Rosenbusch, and V. J. Benedí. 1995. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional structure, and complement binding. Infect. Immun. 63:903-910.
2. Bauernfeind, A., and G. Hörl. 1987. Novel R-factor borne β-lactamase of Esctierichia coli conferring resistance to cephalosporins. Infection 15:257-259.
3. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
4. Chanal, C., D. Sirot, M. Chanal, M. Cluzel, J. Sirot, and R. Cluzel. 1989. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum β-lactamases. J. Antimicrob. Chemother. 24(Suppl. A):133-141.
5. Chow, J. W., and D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28:499-504.
6. Cornaglia, G., L. Guang, R. Fontana, and G. Satta. 1992. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob. Agents Chemother. 36:1902-1908.
7. Cornaglia, G., K. Russel, G. Satta, and R. Fontana. 1995. Relative importance of outer membrane permeability and group 1 β-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob. Agents Chemother. 39:350-355.
8. Filip, C., G. Fletcher, J. L. Wulf, and C. F. Earhart. 1973. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodiumlauryl sarcosinate. J. Bacteriol. 115:717-722.
9. Hopkins, J. M., and K. J. Towner. 1990. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25:49-55.
10. Jacoby, G. A. 1994. Genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):2-11.
11. Jacoby, G. A., and L. Sutton. 1991. Properties of plasmids responsible for extended-spectrum β-lactamase production. Antimicrob. Agents Chemother. 35:164-169.
12. Jacoby, G. A., P. Han, M. Alvarez, and F. Tenover. 1995. Survey of extended-spectrum β-lactamase (ESBL) production in US clinical isolates, abstr. C40, p. 46. In Program and abstracts of the 35th Interscience Conference Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
14. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother 32:691-696.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277:680-685.
16. Livermore, D. M. 1995. β-Lactamases in clinical and laboratory resistance. Clin. Microbiol. Rev. 8:557-584.
17. Livermore, D. M. 1997. Acquired carbapenemases. J. Antimicrob. Chemother. 39:673-676.
18. Mackenzie, F. M., K. J. Forbes, T. Dorai-john, S. G. B. Amyes, and I. M. Gould. 1997. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 350:783.
19. Mainardi, J.-L., P. Mugnier, A. Coutrot, A. Buu-Hoï, E. Collatz, and L. Gutmann. 1997. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob. Agents Chemother. 41:2352-2354.
20. Martínez-Martínez, L., S. Hernández-Allés, S. Albertí, J. M. Tomás, V. J. Benedí, and G. A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:342-348.
21. 20a. Martínez-Martínez, L., A. Pascual, S. Hernández-Allés, D. Alvarez-Díaz, V. J. Benedí, and G. A. Jacoby. 1996. Role of extended-spectrum beta-lactamases (ESBLs) and OmpK36 porin in the activity of antimicrobial agents against Klebsiella pneumoniae, abstr. C37, p. 41. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
23. 21a. Martínez-Martínez, L., A. Pascual, A. I. Suárez, S. Hernández-Allés, D. Alvarez-Díaz, and V. J. Benedí. 1997. Resistance to carbapenems in porins-deficient Klebsiella pneumoniae (Kp) mediated by plasma-encoded AmpC beta-lactamases, abstr. C-94, p. 62. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
25. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. Nicolas, M.-H., V. Jarlier, N. Honore, A. Philippon, and S. T. Cole. 1989. Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33:2096-2100.
27. Osano, E., Y. Arakawa, R. Wacharatuyankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
28. Papanicolau, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
29. Piddock, L. V. J., and H. L. Turner. 1992. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae. Eur. J. Clin. Microbiol. Infect. Dis. 11:1186-1191.
30. Prágai, Z., S. Hernández-Allés, M. C. Conejo, M. D. Alvarez, V. J. Benedí, and L. Martínez-Martínez. 1998. Effect of OmpF/OmpC expression in the activity of cephalosporins and carbapenems against Escherichia coli hyper-producing chromosomal beta-lactamases, abstr. 12009, p. 15. In Program and abstracts of the 8th International Congress of Infectious Diseases. Excerpta Medical Communications, Boston, Mass.
31. Raimondi, A., A. Traverso, and H. Nikaido. 1991. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
32. Rice, L. B., S. H. Marshall, L. L. Carias, L. Sutton, and G. A. Jacoby. 1993. Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum β-lactamase genes. Antimicrob. Agents Chemother. 37:2760-2761.
33. Rice, L. B., S. H. Willey, G. A. Papanicolau, A. A. Medeiros, G. M. Eliopoulus, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother 34:2193-2199.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Sanders, C. C. 1996. In vitro activity of fourth generation cephalosporins against Enterobacteriaceae producing extended-spectrum β-lactamases. J. Chemother. 8(Suppl. 2):57-62.
36. Sanders, W. E., J. H. Tenney, and R. E. Kessler. 1996. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin. Infect. Dis. 23:454-461.
37. Tzouvelekis, L. S., E. Tzelepi, E. Prinarakis, M. Gazouli, A. Katrahoura, P. Giakkoupi, O. Paniara, and N. J. Legakis. 1998. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in greek hospitals. J. Clin. Microbiol. 36:266-268.
38. Yang, Y., P. Wu, and D. M. Livermore. 1990. Biochemical characterization of a β-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob. Agents Chemother. 34:755-758.